BioTheryX, Immuta and Pitch are among the companies that have raised fresh capital from corporates such as Intel Capital, Slack Fund, Citi Ventures and Dell Technologies Capital.

Funding

US-based cancer treatment developer BioTheryX has raised $92m in a series E round backed by Alexandria Venture Investment, the investment arm of life sciences real estate trust Alexandria Real Estate Equities. The round was led by Farallon Capital Management, with participation from additional investors Avidity Partners, Deep Track Capital, Irving Investors, Janus Henderson Investors, Lumira Ventures, Point72, Rock Springs Capital, Surveyor Capital, Tekla Capital Management, Wedbush Healthcare Partners and unnamed existing backers. BioTheryX raised $35m in a series D…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Email LinkedIn